4210-21: When a Pandemic Hits and the Care You Provide is Not "Nonessential": Lessons Learned from Neurotherapeutic Clinics

This presentation discusses new practices put into place for ECT/TMS and Ketamine/Esketamine Services during the COVID pandemic. Lessons learned during that time will help shape how we approach patient care and outreach on an ongoing basis. The participant will understand neurotherapeutics procedures as essential and how they are safely managed.

Presenters:  Paula Bolton, MS, CNP, ANP-BC; Teresa Henderson, BSN, RN; Courtney Miller, BA, ADN, RN

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will be discussed during this presentation.

Session Length:  46 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss risk mitigation measures utilized in neurotherapeutics during the pandemic and how to utilize these safe practices beyond COVID-19.

Keywords:  Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Ketamine Services

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024